Alleima (ALLEI) CMD 2025 summary

Strategic Direction and Market Positioning

• Focus on profitable growth through targeted capital allocation in five priority segments: medical, nuclear, chemical/petrochemical, hydrogen/renewable energy, and industrial heating, aiming for a 6% CAGR in addressable markets.

• Continued shift in business mix to grow targeted segments to 45%-50% of revenue and reduce industrial to 10%-15% by 2030, emphasizing higher profitability and capital efficiency.

• Strong market positions in niche applications, often ranking first or second globally in key segments such as umbilical tubes, medical wire, and compressor valve steel.

• Expansion in APAC and other regions, including new medical wire production in Malaysia and capacity increases in India, China, Germany, Sweden, Japan, the UK, and the US for chemical/petrochemical tubing and other prioritized markets.

• Ongoing investments in R&D and innovation, with a focus on advanced materials, co-development, rapid product feedback cycles, and sustainability-driven products.

Strategy and Long-term Value Creation

• Focus on four strategic pillars: profitable growth, materials innovation, operational excellence, and industry-leading sustainability.

• Growth driven by business development, targeted investments, and M&A in prioritized segments such as medical, nuclear, industrial heating, chemical/petrochemical, and renewables.

• Recent acquisitions enhance capabilities in medical components and high-performance alloys, supporting forward integration and portfolio expansion.

• Strategy execution aims to increase returns on capital, defend market positions, and improve margins.

Financial Performance and Capital Allocation

• Revenues for R12 Q3 2025 reached SEK 19,230 million with an adjusted EBIT margin of 9.2%, up from 7.8% in recent years.

• Improved financial foundation with higher profitability and reduced volatility, driven by disciplined strategy execution.

• Strong balance sheet and cash generation enable continued investments in growth and resilience during downturns; net debt/equity ratio at -0.02x in Q3 2025, with a financial net cash position of SEK 1.5 billion.

• Growth CapEx is primarily allocated to high-return segments, with FY 2025 guidance at SEK ~1,200 million, up from a 2015-2019 average of SEK 750 million.

• Dividend policy targets 50% of net profit over a business cycle.